Higher prices helped offset rising input costs at tissue maker Kimberly-Clark over the past three months.

The company behind Andrex and Kleenex said sales were up 4% on an organic basis across the group – despite falling volumes in Europe over the period.

Total sales for the third quarter hit an all-time high of $5.4bn (£3.37bn). Much of the growth came from the group’s international business, including double-digit improvements in China and South Korea.

“Our focus on targeted growth initiatives and cost reduction allowed us to overcome significant input cost inflation and softer-than-expected demand in portions of the developed markets,” said chief executive Thomas Falk.

“Our market positions remain solid overall and our innovation and marketing programmes are on track. We also continue to generate strong cash flow.”

Read more
No more babies or puppies, says ‘grown up’ Velvet (3 October 2011)
Focus On Household (5 February 2011)
Andrex puppy gets digital makeover (2 December 2010)